Company Profile

CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE407.30-12.05 (-2.87 % )
PREV CLOSE (Rs.) 419.35
OPEN PRICE (Rs.) 426.00
BID PRICE (QTY) 407.20 (11 )
OFFER PRICE (QTY) 408.00 (5 )
VOLUME 1035
TODAY'S LOW / HIGH (Rs.)406.30 426.50
52 WK LOW / HIGH (Rs.)304.75 535
NSE409.00 -11.55 (-2.75 % )
PREV CLOSE(Rs.) 420.55
OPEN PRICE (Rs.) 423.90
BID PRICE (QTY) 409.00 (149 )
OFFER PRICE (QTY) 410.10 (5 )
VOLUME 12104
TODAY'S LOW / HIGH(Rs.) 408.50 427.80
52 WK LOW / HIGH (Rs.)296.05 537.9

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 4.215555
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 23.98
ROCE (%) 58.99
Incorporation Year : 1990

Management Info :

C C Paarthipan - Chairman Sridhar Ganesan - Managing Director

Registered Office :

Address : Narbavi, No . 3,Lakshmanan Street ,T Nagar ,
Chennai,
Tamil Nadu-600017

Phone : 91-044-28156653 / 28156905

Registrar's Details : Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai
Listing : BSE, NSE, Chennai
NEWS More
18Jul07-18-2019$Caplin Point Laboratories’ arm gets USFDA’s nod for Tranexamic Acid Injection Caplin Point Laboratories’

Caplin Point Laboratories’ wholly owned subsidiary -- Caplin Steriles has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Tranexamic Acid Injection USP, 1000mg/10ml (l00mg/mL) vial, a generic therapeutic equivalent version of Cyklokapron Injection, 100 mg/ml, of Pharmacia & Upjohn Company.

According to IQVIA (IMS Health), Tranexamic Acid had US sales data of approximately $30 million for the 12 month period ending March 2019. Caplin Steriles has developed and filed 11 ANDAs on its own and with partners.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

Caplin Point Laboratories’ wholly owned subsidiary -- Caplin..
18Jul07-18-2019$Caplin Point Laboratories informs about press release Caplin Point Laboratories in

Caplin Point Laboratories has informed that it has enclosed press release titled 'Caplin Steriles gets USFDA approval for Tranexamic Acid Injection '.

The above information is a part of company’s filings submitted to BSE.




Caplin Point Laboratories has informed that it has enclosed pre..
18Jul07-18-2019$Caplin Point Laboratories surges on its arm getting USFDA’s nod for Tranexamic Acid Injection Caplin Point Laboratories su

Caplin Point Laboratories is currently trading at Rs. 424.00, up by 10.15 points or 2.45% from its previous closing of Rs. 413.85 on the BSE.

The scrip opened at Rs. 415.45 and has touched a high and low of Rs. 429.80 and Rs. 412.45 respectively. So far 5641 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 535.00 on 10-Sep-2018 and a 52 week low of Rs. 304.75 on 29-Jan-2019.

Last one week high and low of the scrip stood at Rs. 429.80 and Rs. 410.50 respectively. The current market cap of the company is Rs. 3237.51 crore.

The promoters holding in the company stood at 69.03%, while Institutions and Non-Institutions held 7.60% and 23.37% respectively.

Caplin Point Laboratories’ wholly owned subsidiary -- Caplin Steriles has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Tranexamic Acid Injection USP, 1000mg/10ml (l00mg/mL) vial, a generic therapeutic equivalent version of Cyklokapron Injection, 100 mg/ml, of Pharmacia & Upjohn Company.

According to IQVIA (IMS Health), Tranexamic Acid had US sales data of approximately $30 million for the 12 month period ending March 2019. Caplin Steriles has developed and filed 11 ANDAs on its own and with partners.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.


Caplin Point Laboratories is currently trading at Rs. 424.00, u..
12Jul07-12-2019$Caplin Point Laboratories informs about loss of share certificate Caplin Point Laboratories in

Caplin Point Laboratories has informed about loss of share certificate/ issue of duplicate share certificate, pursuant to Regulation 39(3) of SEBI (Listing obligations and disclosure requirement) Regulations 2015.

The above information is a part of company’s filings submitted to BSE.



Caplin Point Laboratories has informed about loss of share cert..
17Jun06-17-2019$USFDA completes inspection at Caplin Point Laboratories’ Steriles Injectable site USFDA completes inspection a

US Food and Drug Administration (USFDA) has completed inspection at Caplin Steriles’ Injectable site at Gummidipoondi between June 6 and June 14, 2019. Caplin Steriles is a Wholly Owned Subsidiary of Caplin Point Laboratories.

At the end of this scheduled GMP inspection, there were only two observations. The company believes these to be of procedural in nature and the corrective and preventive actions for these observations will be presented to the US FDA shortly. The observations made were not repeat observations or related to data integrity.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

US Food and Drug Administration (USFDA) has completed inspectio..
Financials More
Rs. in Millions
QTR Mar 19 ANNUAL 19
Net Profit403.251481.66
Gross Profit 553.31 2026.54
Operating Profit 595.032235.58
Net Sales 1407.435369.06
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Sanofi India (BSE)
 5956.50 (0.73%)
M.Cap ( in Cr)
13672.36
Fredun Pharma (BSE)
 405.00 (3.89%)
M.Cap ( in Cr)
161.58
Everest Organics (BSE)
 157.30 (4.87%)
M.Cap ( in Cr)
125.84
Natco Pharma (BSE)
 510.00 (0.71%)
M.Cap ( in Cr)
9292.59
Denis Chem Lab (BSE)
 42.00 (8.95%)
M.Cap ( in Cr)
58.28
Shareholding Pattern More
PROMOTERS 69.03 %
NON-INSTITUTION 23.37 %
FI/BANKS/INSURANCE 0.03 %
MUTUAL FUNDS/UTI 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
Scheme NameHold(%)
ICICI Pru S&P BSE 500 ETF0.02
F & O Quotes